Seven monoclonal antibodies (mAbs) were developed against neurotoxin I
(NT-1), a protein from central Asian cobra (Naja naja oxiana) venom w
hich binds specifically to nicotinic acetylcholine receptor (AchR). Al
l of the mAbs cross-reacted with another long-chain post-synaptic neur
otoxin, Bungarus multi-cinctus alpha-bungarotoxin (alpha-BT), but not
Naja naja kaouthia alpha-cobratoxin, in an enzyme-linked immunosorbent
assay (e.l.i.s.a.). Short-chain post-synaptic neurotoxins like Naja n
aja atra cobrotoxin, Laticauda semifasciata erabutoxin b, or N. n. oxi
ana neurotoxin II did not cross-react with the NT-1 mAbs, but an antig
en(s) found in Dendroaspis polylepis, Acanthophis antarcticus and Pseu
dechis australis venoms was immunoreactive. The e.l.i.s.a. readings fo
r dithiothreitol-reduced NT-1 and NT-1 mAbs ranged from 13 to 27% of t
hose for native toxin but reduced alpha-BT was not immunoreactive. Syn
thetic NT-1 peptides were used in epitope-mapping studies and two, non
-contiguous regions (Cys(15)-Tyr(23) and Lys(25)-Gly(33) or Pro(17)-Ly
s(25) and Asp(29)-Lys(37)) were recognized by the NT-1 mAbs. The NT-1
mAbs individually inhibited 31-71% of alpha-BT binding to AchR in vitr
o and afforded a slight protective effect in vivo with a toxin:antibod
y mole ratio of 1:1.5. This report is the first to describe mAbs which
recognize and protect against a heterologous, long-chain, post-synapt
ic neurotoxin from snake venom.